How the proto-oncogene c-Myc balances the processes of stem-cell self-renewal, proliferation and differentiation in adult tissues is largely unknown. We explored c-Myc's transcriptional roles at the epidermal differentiation complex, a locus essential for skin maturation. Binding of c-Myc can simultaneously recruit (Klf4, Ovol-1) and displace (Cebpa, Mxi1 and Sin3a) specific sets of differentiation-specific transcriptional regulators to epidermal differentiation complex genes. We found that Sin3a causes deacetylation of c-Myc protein to directly repress c-Myc activity. In the absence of Sin3a, genomic recruitment of c-Myc to the epidermal differentiation complex is enhanced, and re-activation of c-Myc-target genes drives aberrant epidermal proliferation and differentiation. Simultaneous deletion of c-Myc and Sin3a reverts the skin phenotype to normal. Our results identify how the balance of two transcriptional key regulators can maintain tissue homeostasis through a negative feedback loop.
with the finding that c-Myc preferentially binds to promoter regions carrying active chromatin marks 17, 18 , indicated that c-Myc contributes to expression of the majority of active genes in a given cell context. In skin, c-Myc is known to functionally regulate activated progenitor cells and might therefore contribute significantly to both proliferation and differentiation programmes.
Skin differentiation is an excellent system to explore the mechanisms by which c-Myc regulates tissue homeostasis. Epidermal stem cells differentiate into hair follicles, sebaceous glands and interfollicular epidermis (IFE)-and differentiation into IFE can be promoted by c-Myc (ref. 13) . Proliferating IFE daughter cells execute terminal differentiation by migration through suprabasal layers with progressive cornification 19 . IFE differentiation genes are clustered in mammalian genomes as the epidermal differentiation complex (EDC); the mouse EDC is a single 2.2 megabase (Mb) locus on chromosome 3 (refs 20,21) . The EDC concentrates tissue-specific genes, and thus facilitates the analysis of upstream regulatory networks.
We show that c-Myc determines the occurrence of transcriptional regulators and we characterize their collective effect on gene expression. Using a combination of mouse models and systems biology tools, we discover how a negative feedback loop between c-Myc and Sin3a is required to balance proliferation and differentiation.
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RESULTS

EDC genes are bound and directly regulated by c-Myc
To better understand the paradox that activation of a proto-oncogene can lead to increased differentiation ( Supplementary Fig. S1A -D) 2 , we asked whether c-Myc directly regulated genes involved in skin differentiation. We inducibly activated c-Myc in the basal, undifferentiated layer of the mouse epidermis (K14MycER) and carried out chromatin immunoprecipitation combined with chromosome 3 tiling microarrays (ChIP on chip) capturing 61 genes in the EDC (http://www.ensembl.org/index.html; Fig. 1a ). We detected widespread binding of c-Myc to EDC genes, which overlapped with H3K4me3, a histone mark that associates with active transcription start sites ( Fig. 1b ). With the exception of loricrin (Lor) and trichohyalin (Tchh), H3K4me3 and c-Myc binding excluded H3K27me3, an epigenetic mark that is closely linked to transcriptional repression ( Fig. 1b ). Genome-wide analysis using proximal promoter arrays confirmed that c-Myc and H3K4me3 occurrence overlapped by more than 80% and remained unchanged between wild-type and transgenic animals ( Supplementary Fig. S1E ,F and Table S1 ). Most EDC genes (47/55) were expressed above background in wild-type skin (Fig. 1c) , and 17/55 were upregulated after c-Myc activation ( Fig. 1d; red bars) . Conversely, RNA levels of EDC genes were either unchanged or repressed in skin when c-Myc was conditionally deleted (K14Myc / ; Fig. 1d ; blue bars). Direct c-Myc regulation of epidermal differentiation was further evident when we analysed RNA expression levels in c-Myc-depleted skin ( Supplementary Fig. S2A -C). Almost half of all genes that were more than twofold downregulated when c-Myc was deleted were involved in epidermal maturation and differentiation ( Supplementary  Fig. S2A -C and Table S2 ).
Cluster analysis confirmed that a set of EDC genes was upregulated by 4-hydroxytamoxifen (4-OHT)-driven c-Myc activation ( Fig. 2a ). We confirmed a specific regulatory function of c-Myc on EDC genes by comparing their change in RNA expression levels with those of randomly chosen non-EDC genes (Fig. 2b) . During the six-day time course, EDC genes were only upregulated after four to six days of 4-OHT treatment in K14MycER mice (Fig. 2a ). The delay in the EDC's transcriptional response was unusual: virtually all transcriptional changes within the 5,000 genes most dependent on c-Myc activation occurred within one day of 4-OHT treatment ( Fig. 2c , Rasd2, Alox12; Supplementary Table S3 ). In contrast, only 1.7% of genes were upregulated after four to six days, which included the EDC genes ( Fig. 2c, Lcn2 ; Supplementary Table S3 ).
In contrast to the delay in transcriptional regulation, c-Myc bound to EDC genes within a single day of 4-OHT treatment ( Supplementary  Fig. S2D-F ). This disconnection between rapid binding followed by gradual upregulation suggested that c-Myc control of EDC genes might require additional tissue-specific transcription factors.
Myc modulates binding of tissue-specific transcription factors to the EDC
We characterized where nine transcriptional regulators required for skin differentiation bind to the mouse genome: Tfap2c, Cebpa, Cebpb, Ovol-1, Ovol-2, Klf4, Sin3a and Mxi1 (Fig. 3a,b ) [22] [23] [24] [25] [26] [27] [28] . Rbp2 was chosen as an H3K4-specific demethylase 29 . In c-Myc-overexpressing skin, specific clusters of transcription factors increased their shared occupancy of the mouse genome after c-Myc activation ( Fig. 3a ,b, insets; Supplementary Table S4 ), which was even more apparent within the 2.2 Mb containing the EDC (Fig. 3c,d ). Here, we identified two distinct clusters of transcription-factor binding only apparent in K14MycER mice: one contained Klf4, Ovol-1 and c-Myc, and the other Sin3a, Mxi1 and Cebpa ( Fig. 3c,d) . Occupancy of EDC genes by Klf4, Ovol-1, Sin3a, Mxi1 and Cebpa depended directly on the levels of c-Myc ( Fig. 3e ). Whereas trimethylation of H3K4 and H3K27 was comparable between transgenic and wild-type animals, binding of Ovol-1, Klf4, Cebpa, Mxi1 and Sin3a changed considerably when c-Myc was overexpressed ( Fig. 3e ). In wild-type mice with low levels of c-Myc, EDC genes showed little Ovol-1 and Klf4 binding, but were highly bound by Cebpa, Mxi1 and Sin3a (Fig. 3e , lefthand panel). When c-Myc was overexpressed, binding of Cebpa, Mxi1 and Sin3a was markedly reduced; conversely, the binding of Ovol-1 and Klf4 were enhanced ( Fig. 3e ; right-hand panel). The occurrence of transcription factors at EDC genes was not due to direct transcriptional up-or downregulation of the transcription factors by c-Myc, and transcription factors profiled here were coexpressed within the same cellular subpopulations during epidermal differentiation ( Supplementary Fig.  S3A -O). Thus, c-Myc regulates EDC genes by controlling the identity of transcriptional partners present at EDC regulatory regions.
The marked binding changes of epidermal-specific transcription factors at the EDC induced by c-Myc indicate that these factors collectively mediate transcriptional activity ( Fig. 3e ). Among these regulators, only Sin3a principally acts as a transcriptional corepressor; we therefore considered the possibility that Sin3a directly displaces c-Myc to antagonize its function.
Protein interaction with the Sin3a complex targets c-Myc for degradation
We first tested whether Sin3a and c-Myc interact on a protein level. Although we confirmed that Sin3a coimmunoprecipitated with c-Myc ( Fig. 4a ), Sin3a and c-Myc binding to the EDC was mutually exclusive in vivo (Fig. 3e ), indicating that under physiological conditions any interaction of Sin3a with c-Myc was transient. Because c-Myc expression in wild-type epidermis is too low to carry out coimmunoprecipitations, we investigated how Sin3a might remove c-Myc from the promoters. Colour key and histogram 
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Tfap2c c-Myc activates transcription by forming a heterodimer with Max and recruitment of multiprotein complexes including the histone acetyl transferases Kat2a and Kat5 (refs 30-32) . Unlike c-Myc, Max also heterodimerizes with Myc antagonists of the Mxd (Mad) family 27, 33, 34 . Mxd-Max heterodimers repress transcription by recruiting Sin3a/histone deacetylase complexes [35] [36] [37] . As the enzymatic activity of the Sin3a corepressor complex is mediated through histone deacetylase complexes, we speculated that the complex may inhibit acetylation of c-Myc. Acetylation of c-Myc by Kat2a and Kat5 increases its protein stability and transactivation 38 .
Overexpression of Kat2a and Kat5 led to increased acetylation of c-Myc when compared with controls ( Fig. 4b , Ac-Lys; ref. 38) . In contrast, acetylation of c-Myc was decreased in cells overexpressing both the acetyltransferases and Sin3a (Fig. 4b , Ac-Lys). Western blotting for c-Myc, Kat2a, Kat5 and Sin3a confirmed that the proteins were expressed at similar levels ( Fig. 4b ). To test whether deacetylation of c-Myc caused its degradation, we inhibited protein translation using cycloheximide. The protein half-life of c-Myc was reduced when Sin3a was coexpressed ( Fig. 4c and Supplementary  Fig. S4A ). c-Myc RNA levels were the same when Kat2a or
Sin3a were overexpressed and Kat2a and Sin3a proteins were expressed equally ( Supplementary Fig. S4B ,C). Reporter assays demonstrated that transactivation of c-Myc was induced by Kat2a and reduced by Sin3a ( Fig. 4d ).
Depletion of Sin3a in skin induces proliferation and differentiation
To test whether Sin3a negatively regulates c-Myc target genes in vivo, we generated an inducible, conditional-knockout mouse model for Sin3a in the epidermis (Methods; Supplementary Fig. S4D ). We removed Sin3a by topical application of 4-OHT to the mouse back skin and confirmed downregulation of Sin3a on both RNA and protein levels ( Supplementary Fig. S4E -G,L and Fig. 4i ,j,l). Application of 4-OHT in a time course led to an increase of thickness in the IFE (arrows) and sebaceous glands (arrowheads) only in Sin3a-depleted skin ( Fig. 4e-h ; upper and middle panels). Activation of Cre recombinase in RosaLacZ reporter mice confirmed homogenous recombination in the IFE after five days of 4-OHT treatment ( Fig. 4e-h ; lower panels). Neither control mice nor mice with deleted Sin3b (K14Sin3b / ) showed an epidermal phenotype in response to 4-OHT treatment for 14 or 28 days, respectively ( Supplementary Fig. S4H -J), excluding the possibility that the phenotype was due to nonspecific effects of Cre activity, and demonstrating that Sin3b is dispensable for skin homeostasis.
In wild-type skin, Sin3a was expressed throughout the IFE, the sebaceous glands and the hair follicles ( Fig. 4i ). In tail-skin IFE, Sin3a-positive nuclei were enriched towards the basal, undifferentiated layers ( Supplementary Fig. S4K ). Higher expression of Sin3a in undifferentiated cells of the IFE was confirmed on RNA levels ( Supplementary Fig. S3I , left-hand panel).
To confirm a transcriptional interaction between Sin3a and c-Myc in vivo, we isolated epidermal cells from K14Sin3a / mice and tested whether acetylation levels of c-Myc changed with deletion of Sin3a ( Fig. 4k ). Using ImageJ, we measured a 1.4-fold increase in overall acetylation of c-Myc (Ac-Lys) relative to total c-Myc when Sin3a was absent ( Fig. 4k ). Accordingly, nuclear c-Myc was enriched in the IFE when Sin3a was deleted ( Fig Upregulation of c-Myc in the absence of Sin3a led to enhanced proliferation in the IFE (Fig. 5a -c). The number of Ki67-positive cells increased around twofold in both the IFE and sebaceous glands ( Fig. 5d,e ). Analysis of the cell cycle revealed a significant increase in the number of cells in S and G2/M phases on treatment with 4-OHT ( Fig. 5f ), leading to accumulation of Cyclin B1-, Uhrf1-and Mcm2-positive nuclei (Fig. 5g,h and Supplementary Fig. S4M ).
Wholemount labelling of tail skin demonstrated that 5bromodeoxyuridine (BrdU) incorporation in the IFE and sebaceous glands was higher in K14Sin3a / mice than wild-type animals ( Fig. 5i -l; arrows). Thus, in contrast to recent findings in mouse embryonic fibroblasts in which deletion of Sin3a caused proliferation arrest and apoptosis 39, 40 , loss of Sin3a in the epidermis promoted cellular proliferation. This effect was not skin specific and was found also in testis and salivary glands ( Supplementary Fig. S5a -j).
To analyse whether the increased proliferation led to induced differentiation, we labelled sections of back skin for the terminal differentiation markers keratin 10 (Krt10) and involucrin (Ivl). Both markers increased in skin lacking Sin3a ( Fig. 5m-p) . Itga6-positive, undifferentiated layers of the epidermis were also increased on Sin3a deletion ( Fig. 5m-p ). Induced expression of markers for both undifferentiated and differentiated keratinocytes in skin of K14Sin3a / mice was confirmed by quantitative PCR (qPCR; Fig. 5q ).
In summary, deletion of Sin3a in the epidermis increased cellularity in the IFE, which was due to increased proliferation. This increase in cell division was accompanied by enhanced differentiation, demonstrating that Sin3a is dispensable for cells to complete the epidermal terminal differentiation programme.
Loss of Sin3a leads to increased promoter occupancy of c-Myc at EDC genes
To test whether loss of Sin3a led to upregulation of c-Myc-target genes, we carried out ChIP-on-chip experiments on chromosome 3 for c-Myc in skin of K14Sin3a / mice as well as wild-type and K14MycER animals ( Fig. 6a -c, blue bars; Supplementary Table S5 ). Both the number of c-Myc-bound genes and the peak signal, measured as maximal and average peak signal of the combined data, increased when Sin3a was deleted when compared with wild-type skin ( Fig. 6a -c, blue bars). The number of c-Myc bound genes commonly found in K14Sin3a / and K14MycER but not wild-type epidermis increased more than twofold when compared with the number of genes with c-Myc binding only found in wild-type and K14MycER skin ( Fig. 6d and Supplementary Table S5 ).
We also compared Sin3a genomic occupancy in skin of wild-type mice or when c-Myc was either deleted (K14Myc / ) or overexpressed (K14MycER) ( Fig. 6a -c, red bars, and Supplementary Table S5 ). The number of Sin3a peaks as well as the intensity of the signal in wild-type skin was higher than in epidermis that either overexpressed or lacked c-Myc ( Fig. 6a -c, red bars, and Supplementary Fig. S6 ), indicating that a substantial number of Sin3a target genes required the presence of c-Myc.
If our hypothesis that Sin3a detects and removes c-Myc from promoter regions, replacing it with antagonists of the Mxd family, is correct, binding of Mxi1 should similarly to Sin3a depend on the presence and absence of c-Myc. Indeed, the overall number of binding events of Mxi1 remained unchanged in wild-type versus K14Sin3a / epidermis (Supplementary Fig. S7A ,D-G and Table S6 ). As expected, when c-Myc was overexpressed, the number of Mxi1-binding events was reduced (Supplementary Fig. S7A and Table S6 ). Furthermore, deletion of c-Myc led to an increase of both maximum and average peak signal of Mxi1 across chromosome 3 ( Supplementary Fig. S7B,C) . Thus, similarly to Sin3a, enrichment of Mxi1 depended on the presence and absence of c-Myc.
As described earlier, at EDC genes the occurrence of Sin3a was highest in wild-type, lower in epidermis that lacked c-Myc and absent from c-Myc overexpressing skin ( Fig. 6e-g) . In contrast, binding of endogenous c-Myc was enriched on EDC genes when Sin3a was deleted ( Fig. 6h) . Thus, increased differentiation in K14Sin3a / transgenic mice might be due to enhanced c-Myc binding to EDC genes. Indeed, we found a highly similar pattern in RNA expression levels of EDC genes in epidermis that either lacked Sin3a or overexpressed c-Myc (Fig. 6i ). Remarkably, c-Myc-bound genes in K14Sin3a / epidermis overlapped by up to 71% with Sin3a-binding sites in wild-type skin ( Supplementary Fig. S8A and Table S5 ), and only 18% of all c-Mycbound genes in K14MycER skin were never occupied by Sin3a in wildtype or c-Myc-transgenic skin ( Supplementary Fig. S8B and Table S5 ).
Thus, absence of the Sin3a corepressor complex from the epidermis can lead to an enhanced genomic occupancy of c-Myc. 
Sin3a and c-Myc cooperate in regulating genes involved in differentiation and proliferation
We tested whether Sin3a also inhibited Myc activity at target genes involved in cell growth and proliferation. To identify genes that were commonly regulated by Sin3a and c-Myc, we compared messenger RNA transcription in skin of both transgenic mouse models ( Fig. 6j,k) . First, we identified 2,187 genes that were potentially directly regulated by c-Myc by comparing c-Myc binding with genes transcriptionally Max. peak signal S100a1 S100a6 S100a7a S100a8 S100a9 S100a13 S100a14 S100a16 S100a3 S100a4 S100a5 Pglyrp4 
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Flg Hrnr Rptn Tchhl1 S100a11 S100a10 Lce3a Kprp Ivl -0. 1 S100a1 S100a6 S100a7a S100a8 S100a9 S100a13 S100a14 S100a16 S100a3 S100a4 S100a5 Pglyrp4 S100a1 S100a6 S100a7a S100a8 S100a9 S100a13 S100a14 S100a16 S100a3 S100a4 S100a5 Pglyrp4 S100a1 S100a6 S100a7a S100a8 S100a9 S100a13 S100a14 S100a16 S100a3 S100a4 S100a5 Pglyrp4 regulated in skin of K14MycER mice (Fig. 6j , left-hand panel, and Supplementary Table S7 ). Then, we identified 512 genes within this set that were also differentially expressed in K14Sin3a / mice when compared with control mice (Fig. 6k , left-hand panel, and Supplementary Table S7 ). Gene ontology analysis revealed highly similar gene categories for c-Myc-only-and c-Myc/Sin3a-regulated genes (Fig. 6j,k Epgn
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We concluded that, in addition to EDC genes, many other genes involved in cell growth and proliferation were regulated by c-Myc and Sin3a.
Deletion of c-Myc from K14Sin3a / mice restores tissue homeostasis
To test whether the phenotype in K14Sin3a / mice was solely dependent on c-Myc, we generated a conditional double-knockout mouse for Sin3a and c-Myc in the epidermis (Methods) (Fig. 7) . Deletion of c-Myc from K14Sin3a / transgenic mice (K14Myc / Sin3a / ) rescued the skin phenotype: the epidermis resembled that of control mice ( Fig. 7a-d) . Downregulation of c-Myc and Sin3a in this transgenic mouse was confirmed by qPCR ( Fig. 7e ).
We confirmed that epidermal proliferation in the absence of c-Myc and Sin3a was similar to that of controls by labelling cycling cells for Ki67 ( Fig. 7a-d , lower panels, and Fig. 7f ). Indeed, after deletion of both Sin3a and c-Myc, a number of phenotypes reverted to near-normal levels: (1) expression of proliferation and cell-cycle genes twofold upregulated by deletion of Sin3a alone were now either at wild-type levels or decreased (Fig. 7g , left-hand panel, and Supplementary Fig. S8C ); (2) EDC gene expression perturbed by removal of Sin3a was closer to wild-type levels ( Fig. 7g ; right-hand panel); (3) the balance of both undifferentiated and differentiated epidermal layers reverted to normal when both genes were deleted ( Fig. 7h-o) .
Together, the opposing effects of c-Myc and Sin3a on gene transcription are essential to maintain normal skin homeostasis.
DISCUSSION
The underlying mechanisms for c-Myc-induced cellular differentiation are generally thought to be indirect 2 . Our data in mammalian epidermis indicate instead that c-Myc directly controls genes involved in regulating differentiation. Myc directly binds to EDC genes at regions enriched for trimethylation of H3K4 (H3K4me3), a chromatin mark found at active genes, as well as a strong determinant for Myc binding 17, 18 . The chromatin state does not change after activation of c-Myc, supporting a model whereby the deposition of H3K4me3 is independent of c-Myc (refs 1,17) .
The majority of transcriptional changes driven by c-Myc in the genome are immediate. In contrast, the EDC genes directly bound by c-Myc demonstrate a substantial temporal lag in their activation. One explanation for the delay in activation is that the regulatory landscape within the EDC requires remodelling. We demonstrate that specific sets of transcription factors must be removed, and others newly placed, after c-Myc activation. Thus, it seems that c-Myc controls EDC transcription at two levels: it first directly binds EDC genes, but, to regulate gene expression, it then requires the formation of a differentiation-specific regulatory transcription factor network.
The transcription factors recruited to the EDC included Klf4 and Ovol-1, both of which are essential for proper barrier function in skin and both negatively regulate Myc expression 24, 26, 43 . Thus, in later stages of differentiation, Klf4 and Ovol-1 may replace c-Myc at EDC genes to complete the terminal differentiation programme.
The transcription factors displaced from the EDC after c-Myc activation include Cebpa, Mxi1 and its corepressor Sin3a. We further identify Sin3a as the main opposing factor to c-Myc in controlling cellular proliferation and differentiation processes in skin. Sin3a is an important regulator for the maintenance of the adult muscle and testis 44, 45 , and Sin3 complexes have been shown to spread immediately downstream of transcription start sites of both transcribed and repressed genes during myotube differentiation 46 .
The exact biological role that Sin3a plays in tissue-specific regulatory networks is not entirely understood. Sin3a was originally identified as a corepressor associated with the Mxd family of c-Myc antagonists, and was shown to suppress epidermal proliferation 27, [35] [36] [37] . We confirm this hypothesis by showing that tissue-specific deletion of Sin3a from the epidermis induces cellular proliferation through a Myc-dependent pathway. Although, we cannot exclude the possibility that loss of Sin3a in skin leads to a destabilization of the Myc-antagonist repressor complex at chromatin, and thereby enables c-Myc to bind to promoter sequences, we find that at least Mxi1's binding to DNA is unaffected by the absence of Sin3a.
Sin3a is absent from promoter regions when c-Myc is overexpressed and is therefore unable to form a stable repressor complex on chromatin when high levels of c-Myc are bound. Thus, the interaction of Sin3a and c-Myc is most likely indirect through core proteins mediating the deacetylase enzymatic activity. Although we show that overexpression of Sin3a causes deacetylation of c-Myc, leading to decreased protein stability and reduced transactivation, further studies will have to reveal the exact molecular pathway of how deacetylated c-Myc is degraded. Acetylation of c-Myc decreases its ubiquitylation, and thus deacetylation may be linked to the ubiquitin proteosome pathway 47, 48 .
Although Sin3a limits cell proliferation, Sin3a is entirely dispensable for completion of the terminal differentiation programme. The inhibition of proliferation by Mxd-Sin3a complex has been suggested as a mechanism to induce differentiation of primary human keratinocytes 28 . However, many non-proliferating cells in vivo are not terminally differentiated cells; for example, in skin a large number of non-cycling, undifferentiated cells are tightly attached to the basement membrane 49 . Thus, our data indicate that Sin3a is a proliferation inhibitor, but this function is not coupled to terminal differentiation in skin.
Maintaining homeostasis in mammalian tissues is a balance to avoid overproliferation or underproliferation, leading to cancer or tissue failure. How the mechanistic interplay between transcriptional activators and repressors results in stability within tissues has been poorly understood. We identify c-Myc and Sin3a as two master regulators in a mammalian tissue, which can maintain cellular proliferation and differentiation processes by controlling transcriptional balance between activation and repression. . Mouse back or tail skin was treated with 4-OHT as described previously 11, 53 . If not stated otherwise, K14MycER mice were treated with 4-OHT for four days, K14Myc / mice for 21 days and K14Sin3a / mice for 15 days. Mice were compared with either 4-OHT-treated wild-type or vehicle-treated (acetone) transgenic littermates.
METHODS
Methods
Illumina gene-expression microarrays. 250 ng of total RNA was converted to complementary RNA (cRNA) target using the Illumina TotalPrep-96 Kit (Ambion 4397949). Total RNA was reverse transcribed and converted to double-stranded cDNA using a T7promoter-oligo(dT) primer and purified with magnetic oligo(dT) beads. This formed the template for an in vitro transcription reaction, which included a biotinylated nucleotide/ribonucleotide mix for both cRNA amplification and biotin labelling. After purification, quality control and quantity normalization, the cRNA was hybridized to arrays (3 Sentrix BeadChip Array MouseWG-6 v2 part no 11278593). Hybridization, washing, staining and scanning were carried out according to standard Illlumina protocols (Illumina WGGX DirectHyb Assay Guide 11286331 RevA).
ChIP-on-chip analysis.
Back skin of six mice was pooled and used for one ChIP experiment. Isolation of primary mouse keratinocytes and ChIP was carried out as described previously 54 . Sonicated fractions were incubated with 10-15 µg of the following antibodies: c-Myc (sc-764, Santa Cruz), H3K27me3 (07-449, Millipore), H4K3me 3 (ab71998, Abcam or 04-745, Millipore), Cebpa (sc-9314, Santa Cruz), Cebpb (sc-150, Santa Cruz), Sin3a (sc-994, Santa Cruz), Klf4 (sc-20691, Santa Cruz), Ovol-1 and Ovol-2 (provided by X. Dai), Tfap2c (05-909, Millipore), Mxi1 (sc1042, Santa Cruz) and Rbp-2 (provided by E. V. Benevolenskaya).
Immunoprecipitated samples were washed at least four times with RIPA buffer (50 mM HEPES sat pH 7.6, 1 mM EDTA, 0.7% (v/v) Na deoxycholate, 1% (v/v) NP-40 and 0.5 M LiCl) and once with TE buffer (50 mM Tris at pH 8.0, 1 mM EDTA and 1% (w/v) SDS) at 4 • C. Samples were eluted in 200 µl of SDS-based elution buffer, diluted with one volume of TE buffer and treated with RNAse and proteinase K. DNA was extracted with phenol:chloroform and ethanol precipitated. ChIP samples were amplified by ligation-mediated PCR and Cy3-Cy5 labelled as described previously 55 .
Microarray hybridization, washing and scanning was carried out at the Genomics core facility of CR-UK (CRI, Cambridge, UK) according to the standard protocols (http://www.genomics.agilent.com/files/Manual/G4481-90010_ MammalianProtocol_10.11.pdf). ChIP-on-chip experiments were carried out on mouse whole-genome chromosome 3 (Amadid 15317) or proximal promoter Agilent arrays using a minimum of two independent biological replicates.
Microarray and data processing. Analysis of gene expression data involved the use of scripts written in R (R Development Core Team 2008; www.r-project.org) and Bioconductor (www.bioconductor.org; ref. 56 ). Differential gene expression analysis was carried out using limma 57 and time-course analysis using the timecourse package 58 .
ChIP-on-chip data analysis was also carried out in R using Bioconductor, specifically the Ringo package 59 . The R script used to analyse the ChIP-on-chip data is provided as Supplementary Information. To generate the scatterplots for the ChIP-on-chip raw data, the mouse binding events for c-Myc were used as targets to centre each window. A half-size window corresponding to 3,000 base pairs was defined and we set a minimum number of three probes to consider a binding event. Targets were predicted using a 0.90 quantile and genomic regions between 1.0 kilobase (kb upstream and 0.3 kb downstream of the transcription start site of annotated genes from the mouse genome (mm9) were used.
Clustering, annotation and visualization. Microarray data were clustered using Euclidian distance and the 'complete' agglomeration method. These were visualized in R, using the gplots package (Warnes et al. 2010; http://CRAN.R-project.org/ package=gplots). Visualization of the time course of expression for individual genes was also done in R.
Histology, BrdU labelling, tissue staining and cell cycle analysis. Tissues were fixed in 4% (w/v) paraformaldehyde and paraffin embedded, or for cryosections directly embedded in OCT (Raymond A. Lamb). The tissue was sectioned at 5-10 µm for haematoxylin and eosin staining or immunostaining as described elsewhere 11, 12 .
Immunohistochemistry was carried out using Ventana Discovery (Ventana Medical Systems) on paraffin embedded tissues fixed in 4% (w/v) paraformaldehyde, following the manufacturer's guidelines. Antigen retrieval was carried out using Ventana Cell Conditioning 1 solution (Roche) for 40 min at 99 • C. Primary antibody incubation was carried out for 54 min at 37 • C. Secondary antibody incubation (donkey anti-rabbit Ig biotinylated, Jackson or horse anti-goat Ig biotinylated Vector Labs; 1:1,000) was carried out for 30 min at 37 • C. Antibody detection was carried out using the DAB Map kit and sections were counterstained using haematoxylin and bluing reagent (Roche).
The primary antibodies used were Sin3a (1:50; sc-767, Santa Cruz), c-Myc To determine the pattern of recombination at the Rosa26R reporter locus, β-galactosidase analysis was carried out in sectioned skin as described previously 9 . For BrdU labelling, mice were injected with 50 mg of BrdU per kg body weight and killed after 2 h. Wholemounts of mouse tail epidermis were prepared and labelled for immunofluorescence analysis as described previously 53 .
White-field images were acquired using an Olympus IX80 microscope and a DP50 camera. Confocal microscopy images were acquired on a Leica TCS SP5 confocal microscope. Z-stacks were acquired at 100 Hz with an optimal stack distance and 1,024 × 1,024 dpi resolutions. Z-stack projections were generated using the LAS AF software package (Leica Microsystems). All the images were processed with Photoshop CS4 (Adobe) software.
For cell-cycle analysis, cells were fixed with cold 70% (v/v) ethanol and washed with PBS before staining with propidium iodide. After incubating the cells for 1 h in RNase, analysis was carried out on a CyAN ADP analyser (Beckman Coulter). The cell-cycle profile was analysed using FlowJo software.
RNA extraction and semi-quantitative real-time PCR (qPCR). RNA was
isolated from total skin (epidermis and dermis) or cultured cells using trizol reagent (Invitrogen) according to manufacturer's instructions. Double stranded cDNA was generated from 1 µg RNA using superscript III reverse transcriptase (Invitrogen) following the manufacturer's instructions. Real-time PCR amplification and analysis was conducted using the 7900HT real-time PCR system (Applied Biosystems). The standard amplification protocol was used with pre-designed probe sets and TaqMan Fast Universal PCR Master Mix (2×; Applied Biosystems). RNA levels were normalized to GAPDH expression using the Ct method. For luciferase assays, c-Myc, Kat2a, Sin3a and the empty vector control were transfected into HEK293 cells and the Myc reporter assays were carried out according to the manufacturer's instructions (Cignal Myc Reporter; Qiagen).
For c-Myc acetylation analysis, COS7 cells were grown in 150 mm 2 dishes and transfected at 50% confluence with the empty vector, or c-Myc, Kat5, Kat2a and Sin3a constructs with Lipofectamine LTX and Plus Reagent (Invitrogen) and collected after 24 h. To detect endogenous acetylation levels of c-Myc, epidermal cells were isolated from back skin of K14Sin3a f/f mice and cultured as described previously 11 . Cells were treated with 4-OHT or ethanol as a negative control and harvested after 48 h.
All cells were harvested following trypsinization and lysed in lysis buffer consisting of PBS without Ca 2+ and Mg 2+ , 0.5% (v/v) NP-40, 0.1% (w/v) sodium deoxycholate, 0.05% (w/v) SDS and protease inhibitors (Roche). Lysates were then centrifuged at 16,000 × g for 10 min at 4 • C and the supernatant was then added to Protein G Dynabeads (Invitrogen), which had been preincubated with 4 µg of rabbit polyclonal anti-c-Myc antibody (sc-764; Santa Cruz) for 1 h at 4 • C. Following 2 h incubation at 4 • C, beads were washed five times with lysis buffer and immunoprecipitated protein was then eluted with SDS sample buffer at 70 • C. SDS-polyacrylamide gel electrophoresis was then carried out on 10% (w/v) gels and proteins were then transferred onto nitrocellulose membranes. Western blotting was followed by incubation with mouse monoclonal anti acetyl-lysine antibody (1:1,000; Cell Signalling Technology) to detect the amount of acetylated c-Myc. As controls, western blotting was also carried out on whole-cell lysates to detect the amount of total c-Myc (1:250; sc-764, Santa Cruz), Kat5 (1:500: sc-5725, Santa Cruz), Kat2a (1:500; sc-6303, Santa Cruz), Sin3a (1:250; sc-994, Santa Cruz) and tubulin (1:500; ab15246, Abcam). To detect the Flag tag we used ANTI-FLAG (1:500; M2, Sigma). The relative intensity of the bands after western blotting was found using ImageJ. (Table S1 ). 
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